Cadre Holdings, Inc. Selling, General and Administrative Expense
Cadre Holdings, Inc. (CDRE) reported Selling, General and Administrative Expense of $63.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- Cadre Holdings, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $63.22M, a 40.09% increase year-over-year.
- Cadre Holdings, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $48.83M, a 16.96% increase year-over-year.
- Cadre Holdings, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $50.62M, a 12.37% increase year-over-year.
- Cadre Holdings, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $45.63M, a 34.27% increase year-over-year.
- Cadre Holdings, Inc. selling, general and administrative expense for fiscal 2025 was $183.13M, a 15.67% increase from fiscal 2024.
- Cadre Holdings, Inc. selling, general and administrative expense for fiscal 2024 was $158.32M, a 12.67% increase from fiscal 2023.
- Cadre Holdings, Inc. selling, general and administrative expense for fiscal 2023 was $140.52M, a 8.23% decline from fiscal 2022.
- Cadre Holdings, Inc. selling, general and administrative expense for fiscal 2022 was $153.13M, a 33.20% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $63.22M 10-Q · filed 2026-08-05 | $112.05M 10-Q · filed 2026-08-05 | $162.67M derived: sum of 3 quarters · filed 2026-08-05 | $208.30M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $48.83M 10-Q · filed 2026-05-11 | $99.45M derived: sum of 2 quarters · filed 2026-05-11 | $145.08M derived: sum of 3 quarters · filed 2026-05-11 | $190.21M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $50.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $96.25M derived: sum of 2 quarters · filed 2026-03-10 | $141.38M derived: sum of 3 quarters · filed 2026-08-05 | $183.13M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $45.63M 10-Q · filed 2025-11-04 | $90.76M derived: sum of 2 quarters · filed 2026-08-05 | $132.51M 10-Q · filed 2025-11-04 | $177.56M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $45.13M 10-Q · filed 2026-08-05 | $86.88M 10-Q · filed 2026-08-05 | $131.93M derived: sum of 3 quarters · filed 2026-08-05 | $165.91M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $41.75M 10-Q · filed 2026-05-11 | $86.80M derived: sum of 2 quarters · filed 2026-05-11 | $120.78M derived: sum of 3 quarters · filed 2026-05-11 | $159.36M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $45.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $79.03M derived: sum of 2 quarters · filed 2026-03-10 | $117.60M derived: sum of 3 quarters · filed 2026-03-10 | $158.32M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $33.98M 10-Q · filed 2025-11-04 | $72.56M derived: sum of 2 quarters · filed 2025-11-04 | $113.28M 10-Q · filed 2025-11-04 | $148.18M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $38.58M 10-Q · filed 2025-08-05 | $79.30M 10-Q · filed 2025-08-05 | $114.20M derived: sum of 3 quarters · filed 2026-03-10 | $150.51M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $40.72M 10-Q · filed 2025-05-06 | $75.62M derived: sum of 2 quarters · filed 2026-03-10 | $111.94M derived: sum of 3 quarters · filed 2026-03-10 | $145.99M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $34.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $71.22M derived: sum of 2 quarters · filed 2026-03-10 | $105.27M derived: sum of 3 quarters · filed 2026-03-10 | $140.52M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $36.31M 10-Q · filed 2024-11-06 | $70.36M derived: sum of 2 quarters · filed 2024-11-06 | $105.61M 10-Q · filed 2024-11-06 | $140.31M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $34.05M 10-Q · filed 2024-08-09 | $69.30M 10-Q · filed 2024-08-09 | $104.00M derived: sum of 3 quarters · filed 2025-03-11 | $135.73M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $35.25M 10-Q · filed 2024-05-08 | $69.95M derived: sum of 2 quarters · filed 2025-03-11 | $101.68M derived: sum of 3 quarters · filed 2025-03-11 | $134.43M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | $34.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $66.43M derived: sum of 2 quarters · filed 2025-03-11 | $99.18M derived: sum of 3 quarters · filed 2025-03-11 | $153.13M 10-K · filed 2025-03-11 | $153.29M 10-K · filed 2023-03-15 |
| 2022-09-30 | $31.73M 10-Q · filed 2023-11-08 | $64.48M derived: sum of 2 quarters · filed 2023-11-08 | $118.43M 10-Q · filed 2023-11-08 | $146.22M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-06-30 | $32.75M 10-Q · filed 2023-08-08 | $86.70M 10-Q · filed 2023-08-08 | $114.49M derived: sum of 3 quarters · filed 2024-03-12 | $142.17M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-03-31 | $53.95M 10-Q · filed 2023-05-09 | $81.74M derived: sum of 2 quarters · filed 2024-03-12 | $109.42M derived: sum of 3 quarters · filed 2024-03-12 | $140.86M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2021-12-31 | $27.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $55.47M derived: sum of 2 quarters · filed 2024-03-12 | $86.91M derived: sum of 3 quarters · filed 2024-03-12 | $114.96M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $27.67M 10-Q · filed 2022-11-10 | $59.12M derived: sum of 2 quarters · filed 2022-11-10 | $87.17M 10-Q · filed 2022-11-10 | $113.83M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $31.44M 10-Q · filed 2022-08-11 | $59.49M 10-Q · filed 2022-08-11 | $86.16M derived: sum of 3 quarters · filed 2022-08-11 | $113.07M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $28.05M 10-Q · filed 2022-05-16 | $54.72M derived: sum of 2 quarters · filed 2022-05-16 | $81.62M derived: sum of 3 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $26.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $53.57M derived: sum of 2 quarters · filed 2022-03-11 | $106.63M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $26.91M 10-Q · filed 2021-12-02 | $79.96M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |